Initial experience of percutaneous pulmonary valve implantation using self-expanding valve

Wen-zhi PAN,Lei ZHANG,Xiao-chun ZHANG,Li-hua GUAN,Cui-zhen PAN,Da-xin ZHOU,Jun-bo GE
DOI: https://doi.org/10.3969/j.issn.1674-7372.2016.07.015
2016-01-01
Abstract:Objective To evaluate the safety and e?cacy of percutaneous pulmonary valve implantation (PPVI) using the domestic Venus P. Method 14 cases of patients who underwent PPVI in our hospital from May 2013 to May 2016 and completed 3 months follow-up were enrolled in the study. The success rate of procedure, incidence of complications, valve functions and changes of symptoms were analyzed. Result A total of 14 patients, included 3 males and 11 females, with an average age of (35.1±7.6) years old, all had chronic pulmonary regurgitation (PR) after right ventricular outflow tract (RVOT) reconstruction using the trans-annular patch. The procedure success rate was 100%. The positions of valve were satisfied and no valve dislodgement occurred in all patients. 1 case had fever one day after procedure and was cured by antibiotics and steroids. 1 case had atrial flutter 3 months after procedure and was cured by electrical cardioversion. 3 months follow-up after procedure showed that NYHA grades were significantly improved, 6 minutes walk distances increased. Echocardiography showed that there was no pulmonary valve regurgitation severer than mild, no paravalvular regurgitation, and the trans-valvular pressure gradient was (16.9±6.3) mmHg. Chest X rays showed that structure of the valve stents was complete and no valve dislodgement occurred in all patients. ECG showed QRS wave duration was significantly shortened. Conclusion Our initial experience showed that using Venus P in PPVI was safe and effective for Chinese patients with chronic PR after surgery for congenital heart disease, but it needs to be confirmed by further follow up and larger sample size studies.
What problem does this paper attempt to address?